Boston University
Acral lentiginous melanoma in skin of color: biology, diagnostic delay, and health disparities
Abstract
dc:description.abstractAcral lentiginous melanoma is a rare subtype of melanoma that disproportionately affects darker-skinned people of color, primarily African Americans, Hispanic, and Asian populations. Lentiginous refers to the tumor’s radial growth phase before it starts invading the dermis. Compared to other melanomas, it seems to have a UV-independent path based on its development in sun-shielded locations. However, it is believed to have a positive correlation to trauma seeing as the soles of the feet, the most common manifestation sites, are weight bearing and are under the most mechanical stress. ALM lesions are often misdiagnosed and therefore not caught in time to be surgically removed This delay in diagnosis may be due to lack of awareness in both patients and clinicians, racial disparities, and the heterogeneity of the tumor. These factors essentially delay treatment and propagate the disparity in survival rates between darker skinned ethnic minorities and non-Hispanic, White populations. ALM is an understudied, aggressive disease that needs to be treated just as aggressively. Although there is ongoing research on viable treatment options for this disease, currently there are no effective interventions. However, closing these gaps and finding effective solutions requires a shift toward inclusive, multidisciplinary efforts.
Degree
thesis:*- Name thesis:degree_name
- Master of Science
- Level thesis:degree_level
- masters
- Discipline thesis:degree_discipline
- Medical Sciences
- Grantor
- Boston University
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Adrien Nuel, Alina
- Advisors dc:contributor.advisor
-
- Offner, Gwynneth
- Symes, Karen
Subjects
dc:subject × 3Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/53154